240 related articles for article (PubMed ID: 2958955)
1. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains.
Soria J; Soria C; Samama M; Tabori S; Kehl M; Henschen A; Nieuwenhuizen W; Rimon A; Tatarski I
Thromb Haemost; 1987 Jun; 57(3):310-3. PubMed ID: 2958955
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
[TBL] [Abstract][Full Text] [Related]
4. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.
Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M
J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
[TBL] [Abstract][Full Text] [Related]
7. The polymerization of fibrin prepared from fibrinogen Haifa (gamma 275Arg----His).
Siebenlist KR; Mosesson MW; Di Orio JP; Tavori S; Tatarsky I; Rimon A
Thromb Haemost; 1989 Nov; 62(3):875-9. PubMed ID: 2512677
[TBL] [Abstract][Full Text] [Related]
8. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
Matsuda M; Baba M; Morimoto K; Nakamikawa C
J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
[TBL] [Abstract][Full Text] [Related]
9. Normal plasmic cleavage of the gamma-chain variant of "fibrinogen Saga" with an Arg-275 to His substitution.
Yamazumi K; Terukina S; Onohara S; Matsuda M
Thromb Haemost; 1988 Dec; 60(3):476-80. PubMed ID: 2976995
[TBL] [Abstract][Full Text] [Related]
10. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S
Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400
[TBL] [Abstract][Full Text] [Related]
13. Plasmic degradation of fibrinogen Paris I.
Budzynski AZ; Marder VJ
J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
[TBL] [Abstract][Full Text] [Related]
14. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
Schwartz LB; Bradford TR; Littman BH; Wintroub BU
J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
[TBL] [Abstract][Full Text] [Related]
15. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
[TBL] [Abstract][Full Text] [Related]
16. Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogen.
Southan C; Thompson E; Panico M; Etienne T; Morris HR; Lane DA
J Biol Chem; 1985 Oct; 260(24):13095-101. PubMed ID: 2932434
[TBL] [Abstract][Full Text] [Related]
17. [Chemical properties of plasma fibrinogens and fibrins from normal and cobalt-treated rabbits].
Lober M; Krantz S
Acta Biol Med Ger; 1975; 34?710():1573-88. PubMed ID: 1233845
[TBL] [Abstract][Full Text] [Related]
18. A new genetic fibrinogen variant (fibrinogen Erfurt I). Structurally characterized by an abnormal B beta-chain and present both in plasma and platelets.
Meyer M; Schellenberg I; Vogel G; Bischoff I
Thromb Haemost; 1988 Apr; 59(2):138-42. PubMed ID: 3388290
[TBL] [Abstract][Full Text] [Related]
19. The polymerization of fibrinogen Dusart (A alpha 554 Arg-->Cys) after removal of carboxy terminal regions of the A alpha-chains.
Siebenlist KR; Mosesson MW; DiOrio JP; Soria J; Soria C; Caen JP
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):61-5. PubMed ID: 8457653
[TBL] [Abstract][Full Text] [Related]
20. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
